{
    "nctId": "NCT05806632",
    "briefTitle": "Prognostic Relevance of Coagulation Activation in RIsk Assessment and Stratification",
    "officialTitle": "Prognostic Relevance of Coagulation Activation in RIsk Assessment and Stratification in Reference to Patient Important Outcomes for Locally Advanced Breast Cancer: The ARIAS Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Local Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 108,
    "primaryOutcomeMeasure": "Pathological response rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with normal organ functions\n* Cytologically/histologically proven breast cancer, stage IIB-IIIC\n* Participants must not have prophylactic or therapeutic indications for anticoagulants.\n\nExclusion Criteria:\n\n* Pregnacy\n* Metastatic breast cancer\n* Previous chemotherapy, hormone therapy, radiotherapy\n* Previous malignancies or contralateral breast cancer",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}